Bruker Corporation (BRKR) P/E Ratio History
Historical price-to-earnings valuation from 2000 to 2025
Loading P/E history...
BRKR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Bruker Corporation (BRKR) trades at a price-to-earnings ratio of 55.7x, with a stock price of $42.30 and trailing twelve-month earnings per share of $-0.06.
The current P/E is 28% above its 5-year average of 43.4x. Over the past five years, BRKR's P/E has ranged from a low of 25.2x to a high of 80.3x, placing the current valuation at the 85th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, BRKR trades at a 151% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, BRKR commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BRKR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BRKR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $21B | 32.5 | 6.27 | +0% | |
| $15B | 36.2 | 14.75 | -71% | |
| $19B | 34.7 | - | -26% | |
| $33B | 25.8 | 1.75Best | +3% | |
| $176B | 26.7 | 12.62 | +7% | |
| $27B | 31.5 | 2.84 | +4% | |
| $36B | 24.7 | 2.57 | -1% | |
| $124B | 34.7 | - | -5% | |
| $22B | 26.2 | 6.18 | +171%Best | |
| $7B | 9.3Lowest | - | +143% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
BRKR Historical P/E Data (2000–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $41.20 | $0.52 | 79.2x | -1% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $41.74 | $0.52 | 80.3x | +0% |
| FY2024 Q4 | $58.62 | $0.76 | 77.1x | -4% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $69.06 | $2.08 | 33.2x | -59% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $63.81 | $2.41 | 26.5x | -67% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $93.94 | $2.75 | 34.2x | -57% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $73.48 | $2.92 | 25.2x | -69% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $62.30 | $2.17 | 28.7x | -64% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $73.92 | $2.16 | 34.2x | -57% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $78.84 | $2.10 | 37.5x | -53% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $68.35 | $1.99 | 34.3x | -57% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $53.06 | $1.83 | 29.0x | -64% |
Average P/E for displayed period: 80.2x
See BRKR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BRKR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BRKR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBRKR — Frequently Asked Questions
Quick answers to the most common questions about buying BRKR stock.
Is BRKR stock overvalued or undervalued?
BRKR trades at 55.7x P/E, above its 5-year average of 43.4x. The 85th percentile ranking indicates a premium to historical valuation.
How does BRKR's valuation compare to peers?
Bruker Corporation P/E of 55.7x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is BRKR's PEG ratio?
BRKR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2000-2025.